Colibactin is an assumed human gut bacterial genotoxin, whose biosynthesis is linked to the clb genomic island that has a widespread distribution in pathogenic and commensal human enterobacteria. Colibactin-producing gut microbes promote colon tumour formation and enhance the progression of colorectal cancer via cellular senescence and death induced by DNA doublestrand breaks (DSBs); however, the chemical basis that contributes to the pathogenesis at the molecular level has not been fully characterized. Here, we report the discovery of colibactin-645, a macrocyclic colibactin metabolite that recapitulates the previously assumed genotoxicity and cytotoxicity. Colibactin-645 shows strong DNA DSB activity in vitro and in human cell cultures via a unique copper-mediated oxidative mechanism. We also delineate a complete biosynthetic model for colibactin-645, which highlights a unique fate of the aminomalonate-building monomer in forming the C-terminal 5-hydroxy-4-oxazolecarboxylic acid moiety through the activities of both the polyketide synthase ClbO and the amidase ClbL. This work thus provides a molecular basis for colibactin's DNA DSB activity and facilitates further mechanistic study of colibactin-related colorectal cancer incidence and prevention.
T he human microbiota is a massive consortium of all microbes that reside in and on human bodies. These microbes are increasingly being correlated to human health and disease, but the underlying molecular mechanisms of human-microbe interactions often remain elusive 1, 2 . Interrogating the specialized metabolites produced by human microbiota allows a thorough study of chemical regulatory and signalling processes, and improves our understanding of the interplay between microbiota and host at a molecular level. Despite the importance of these small molecules in human health and disease, it is often challenging to characterize them because of the difficulty in the culture and genetics of producing microbes and the low titres of these metabolites [3] [4] [5] .
A well-known example of such a specialized metabolite is colibactin, a cryptic human gut bacterial genotoxin that has captured the attention of both biologists and chemists due to its significant effects on human health and intriguing biosynthetic logic [6] [7] [8] . The biosynthesis of colibactin is linked to a 54-kilobase non-ribosomal peptide synthetase (NRPS)-polyketide synthase (PKS) hybrid gene cluster 9 (the clb pathogenicity island ( Supplementary Fig. 1) ), which has been phenotypically associated with the pathogenesis of colorectal cancer (CRC) [9] [10] [11] [12] [13] [14] [15] . In particular, in vitro infection with Escherichia coli strains that harbour the clb island induced DNA double-strand breaks (DSBs) in cultivated human cells, which leads to cell cycle arrest and eventually cell death 9 . Subsequent physiological studies showed that clb + bacteria induced in vivo DNA damage and genomic instability in enterocytes 10 , caused cellular senescence 11, 12 , increased intestinal permeability 13 and promoted colon tumour formation in mouse models of chronic intestinal inflammation 12, 14, 15 , which suggests that these bacteria could promote human CRC development on a broader level 8 . Consistently, clb + E. coli was over-represented in biopsies isolated from CRC patients compared to non-CRC controls (~60% versus ~20%, respectively) 14, 16 . In addition to its remarkable association with human health, the clb island was also identified in the genomes of other proteobacteria, including coral and honeybee symbionts, which suggests that colibactin might play an even more comprehensive role in mediating evolutionarily conserved or consistent interactions between bacteria and hosts 17, 18 .
Given the physiological importance of intestinal pathology induced by human body's microscopic residents, it is urgent to reveal the molecular identity of genotoxic colibactin as the missing link between certain gut microbes and DNA DSBs and decode the mechanism that underlies colibactin-induced DNA damage. Despite tremendous efforts, colibactin's structural elucidation remains a formidable challenge due to its instability, low titre and the elusive and complex biosynthetic logic of clb pathway [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . This knowledge gap has prevented comprehensive studies of colibactinrelated CRC incidence and prevention, and limited mechanistic investigations of the even more extensive influence of the clb island on microbe-host interactions.
To investigate the corresponding genotoxic colibactin that possesses intrinsic DNA DSB activity and causes chromosome aberrations, three issues need to be addressed. (1) The mutation of individual clb genes revealed that all the genes that encode NRPS-PKS and associated biosynthetic enzymes are indispensable to the genotoxicity of the clb island 9,26 ( Supplementary Fig. 1) ; however, the colibactin metabolite that requires all of the clb genes for its biogenesis has not been identified. ( 2) The precise role of ClbP, a membrane-bound peptidase that was proposed to be important for colibactin maturation 19, 20 ( Supplementary Fig. 1 ), remains unknown. (3) The induction of DNA DSBs has been defined as a signature feature of the clb island 6-10 , yet conclusive evidence that colibactin directly mediates DNA breakage is still lacking, even
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though precolibactin-546 (5) showed a weak DNA crosslinking activity in vitro in the presence of reducing agents 24 (Fig. 1a ). Of the many types of DNA damage that exist within cells, the DNA DSBs are considered to be the most hazardous lesions 30 , which suggests the remarkable cytotoxicity of the yet-to-be-identified colibactin metabolite that exerts a direct DNA DSB activity. Here we report the structural elucidation of a new mature macrocyclic colibactin metabolite, and further show that the macrocyclic colibactin induces DNA DSBs in vitro and in various human cell cultures via a unique copper-mediated oxidative mechanism.
Results
Discovery of complete colibactin precursor. Our previous efforts to identify colibactin biosynthetic intermediates resulted in the structural elucidation of precolibactin-886 (10) 28 , which was isolated from a clb + heterologous expression strain E. coli DH10B/ pCAP01-clb with disrupted clbP and clbQ that encode a peptidase and a type II thioesterase that mediates the offloading of clb pathway intermediates, respectively 19, 28, 31 (Fig. 1 ). The double mutation of ΔclbPΔclbQ increased the titre of downstream metabolites from the NRPS-PKS assembly line, which enabled the structural characterization of 10 whose biogenesis requires all the components of the megasynthase assembly line except the PKS ClbO 28 . We then searched for a more complete colibactin derivative that could account for the activity of ClbO. The initial examination of the ΔclbPΔclbQ and ΔclbPΔclbQΔclbO mutants for the selective loss of metabolites identified a precolibactin metabolite with m/z 970 (named precolibactin-969 (11)) in a trace amount (Figs. 1 and 2a). To facilitate the structural elucidation of 11, additional regulatory or resistance clb genes, which included clbR and clbS, were explored to probe their effects on the production of 11. ClbR is a known positive transcriptional regulator and its overexpression previously led to a fivefold increase in the prodrug motif accumulation 22 , and ClbS is a colibactin resistance protein that was proposed to sequester or modify colibactin and thereby prevent self-inflicted DNA damage 32, 33 . Although overexpression of clbR had no obvious effect on the titre of 11, inactivation of clbS resulted in a notable fourfold increase in the titre of 11 along with other precolibactins ( Fig. 2a and Supplementary Fig. 2 ). The observed eliciting phenomenon in ΔclbS is consistent with the proposed function of ClbS, and we thus used the ΔclbPΔclbQΔclbS mutant strain for the subsequent precolibactin production and purification.
From a 2,000 l fermentation culture of ΔclbPΔclbQΔclbS, 50 µg of 11 was obtained after extraction with organic solvent followed by multiple rounds of reversed-phase liquid chromatography purification. 11 was isolated as a white and amorphous powder, and its molecular formula was determined as C 44 H 59 N 9 O 12 S 2 by highresolution mass spectrometry (HRMS) (m/z 970.3799, calculated 970.3797) ( Supplementary Fig. 3 ), which has an additional C 3 HNO 2 compared to the formula of 10. The presence of an extra nitrogen atom in 11 is consistent with the known aminomalonate substrate utilization by ClbO 26, 27 , also supported by the isotope-labelled precursor feeding experiments, which suggests the incorporation of an additional aminomalonate compared to 10 ( Supplementary Fig. 4 ). Similar to 10, 11 was isolated as an approximately equal mixture of two diastereomers ( Supplementary Fig. 5 ). Analysis of extensive NMR spectra and high-resolution tandem mass spectrometry (HRMS n ) fragmentation data demonstrated that 11 and 10 share the same macrocyclic scaffold from C-1 to C-40 ( Fig. 1 ), which indicates that ClbO functions towards the end of the NRPS-PKS assembly line to incorporate the last building monomer of aminomalonate. However, we were not able to assign the structure of this extra region (C-41 to C-44) based on the NMR spectra due to the apparent proton deficiency feature and the extremely low titre of 11 at this stage.
We then turned to the PKS activity of ClbO to predict the fate of the corresponding aminomalonate unit. In the clb locus, two PKS modules, ClbK PKS and ClbO, were enzymatically established to incorporate an aminomalonate extender unit 26, 27 . Both PKS modules have domains organized into KS-AT*-ACP ( Fig. 1b) . A maximum likelihood tree revealed a close phylogenetic relationship between these two KS domains ( Supplementary Fig. 8 ), which suggests ClbK PKS and ClbO have a similar activity. Although ClbK PKS was shown to incorporate aminomalonate through a decarboxylative Claisen condensation to form 10 ( Fig. 2b) , this reactivity does not account for the addition of three carbon atoms promoted by ClbO in forming 11. Given the typical observation that the titres of upstream colibactin metabolites were significantly higher than those of the downstream metabolites 25,28 , we searched for a possible intermediate that is stalled at ClbK PKS with an additional of C 3 HNO 2 in its molecular formula compared to precolibactin-712 (7) to facilitate the total structural determination of 11 ( Fig. 1 ). Careful analysis of the culture extracts of ΔclbPΔclbQΔclbSΔclbO revealed a new metabolite (named precolibactin-795a (8)) with the molecular formula C 39 H 53 N 7 O 9 S 1 (m/z 796.3697, calculated 796.3698) ( Fig. 2c and Supplementary Fig. 9 ). A total of 1.1 mg of 8 from a 500 l fermentation culture was obtained and extensive analysis of the NMR spectra and HRMS n fragmentation data indicated that in comparison with 7 and precolibactin-795b (9), 8 contains a unique 5-hydroxyoxazole moiety next to the terminal carboxyl group ( Fig. 1 3 ). We proposed that to assemble 8, the aminomalonate unit is incorporated into the assembly line through nucleophilic attack of the amine in the aminomalonate extender unit on the upstream peptidyl-S-T thioester of ClbJ, followed by synchronous cyclization and release ( Figs. 1 and 2d ). This novel biosynthetic logic of accommodating a rare aminomalonate building block was further supported by the gene inactivation and isotope-labelled precursor feeding experiments ( Fig. 2c and Supplementary Fig. 4 ). We thus deduced that 11 contains the same 5-hydroxyoxazole moiety next to its terminal carboxyl group, which is derived from the aminomalonate extender unit of ClbO and formed through the same chemical logic as for 8 ( Figs. 1 and 2e ). Furthermore, a precolibactin metabolite (precolibactin-943 (12)) with m/z 944, corresponding to the decarboxylative condensation activity of ClbO, was also observed ( Supplementary Fig. 13 ), but its titre was only approximately 10% of that of 11. Additional gene inactivation experiments showed that ClbL, a putative amidase, was required for the biosynthesis of 8 and 11, but not 9, 10 and 12, which suggests that ClbL promotes the nucleophilic attack of the amine in the aminomalonate extender unit (Figs. 1 and 2).
Maturation of colibactin.
Precolibactin-969 (11) is hitherto the largest colibactin derivative that requires all the components of the NRPS-PKS assembly line for its biosynthesis. We next examined whether ClbP, the dedicated peptidase for colibactin maturation, is capable of hydrolysing this precursor in the bacterial periplasm and releasing the mature colibactin ( Fig. 3a ). Incubation of 11 with the culture of E. coli that expresses ClbP resulted in the complete loss of 11 and the production of both the prodrug motif N-myristoyld-asparagine (14) and a new metabolite (named colibactin-645 (13)) with the molecular formula of C 26 H 27 N 7 O 9 S 2 (m/z 646.1394, calculated 646.1384) ( Fig. 3 and Supplementary Fig. 14) . 13 was confirmed to be the mature compound of 11 with a free N terminus after cleavage and release of the prodrug motif based on the comparative HRMS/MS analysis ( Supplementary Fig. 14) . It is notable that, unlike 11 and 14, 13 is a very water-soluble compound that could not be extracted by typical organic solvents, such as ethyl acetate 21, 24 . Additionally, we observed a significantly increased recovery yield of 13 from the ClbP-expressing E. coli culture on treatment with metal chelators, such as ethylenediaminetetraacetic acid (EDTA) and Chelex-100 ( Fig. 3b ). The positive effect of metal chelators on the metabolite yields from E. coli cultures was also observed for 11, but not for other precolibactins such as 2, 5 and 7 ( Supplementary Fig. 15 ). These results suggested the susceptibility of colibactin-645 (13) and its precursor (11) to trace metals for possible degradation.
Colibactin production by a native strain. We next investigated whether the native clb + E. coli strain could produce the same colibactin-645 to probe if 13 was a native metabolite or an artefact that arises from a non-natural biosynthetic pathway in a heterologous host. Liquid chromatography-mass spectrometry (LC-MS) analysis of cell-free culture extracts of the wild-type clb + E. coli CFT073 (7), precolibactin-795a (8), precolibactin-795b (9), precolibactin-886 (10) and precolibactin-969 (11 and its clbmutant revealed a peak identical to 13 only in the wildtype clb + strain, which confirms that 13 is the native product of the clb pathogenicity island (Fig. 3b ). It is notable that, after enrichment from a 2 l of fermentation culture, only a trace amount of 13 was detected by HRMS analysis, which indicates the low titre of 13 or its chemical lability. As previous work showed that a direct contact between bacterial and eukaryotic cells was required for the full toxicity of colibactin 9 , we further examined whether the majority of 13 is associated with the producing cells. 13 was not detected in the cellular extract of clb + E. coli CFT073 (Fig. 3b ), which suggests that the mature colibactin was secreted after production and was highly unstable after secretion.
DNA DSB activity of colibactin in vitro.
After obtaining the highly sought mature colibactin (13), we examined its DNA DSBs in vitro using the pBR322 plasmid DNA strand scission assay, a surrogate test for DNA damage 34 . Although 13 showed sparse DNA damage activity on incubation with DNA, in the presence of Cu(ii), but not other metals such as Fe(iii) and Fe(ii), both 13 and its precursor precolibactin-969 (11) caused significant DNA breakage with the formation of both nicked (Form II) and linearized (Form III) DNA from the supercoiled plasmid DNA (Form I) ( Fig. 4a and Supplementary Fig. 16 ). As 13 and 11 demonstrated comparable DNA damage activities in initial tests, we used 11 as an appropriate substitute for 13 in the subsequent in vitro assays because 11 was more readily available. A time-course experiment of DNA cleavage was then performed to determine if the colibactin-induced linearized DNA arose from coupled strand-cleavage events (DSBs) or from an accumulation of unrelated single-strand breaks (SSBs). All three forms of DNA were visible on the gel, which shows classical evidence of DSBs (Fig. 4b) . A Freifelder-Trumbo analysis was further performed to calculate the number of SSBs (n 1 ) and DSBs (n 2 ) per molecule of DNA after treatment with 11 at various time points, which resulted in a constant ratio of SSBs to DSBs (5.35:1) ( Supplementary Fig. 17 ). This number is significantly lower than the 120:1 ratio expected if DSBs were to arise from an accumulation metabolic extracts from ΔclbPΔclbQ, ΔclbPΔclbQΔclbS and its ten mutants, and from ΔclbPΔclbQΔclbS::clbR, shows the impact of gene knockout or knock-in on the yield of 11, and the requirement of clb pathway genes for the biosynthesis of 11. EIC+ = 970.38 ± 0.01 (EIC, extracted-ion chromatogram), which corresponds to 11. b, Proposed mechanism of ClbK PKS that underlies the production of 10. The chain elongation is achieved through C−C bond formation by a decarboxylative Claisen condensation. c, A comparison of LC-MS extracted ion chromatogram traces of the metabolic extracts from ΔclbPΔclbQΔclbS and its ten mutants. EIC+ = 796.37 ± 0.01 and 796.35 ± 0.01, which correspond to 8 and 9, respectively. d, Proposed mechanism of ClbK PKS and ClbL that underlies the production of 8. The chain elongation is achieved through C−N bond formation by nucleophilic attack of the amine in the aminomalonate extender unit, followed by synchronous cyclization and the release of 8. e, Proposed mechanism of ClbO and ClbL that underlies the production of 11 with a similar biosynthetic logic to that of 8. (11) is biosynthesized in the cytoplasm of E. coli strains by the clb biosynthetic pathway and transported via ClbM into the periplasm, whereby the membrane-bound peptidase, ClbP, cleaves 11 to generate mature colibactin-645 (13) and a prodrug motif N-myristoyl-d-asparagine (14) , followed by outer membrane translocation. b, A comparison of LC-MS extracted ion chromatogram traces shows that the production of 13 resulted from its precursor 11 cleavage by E. coli strains that express the peptidase gene clbP in the presence or absence of metal chelators, and shows the detection of a metabolite identical to 13 from either cell-free culture extracts or cellular extracts of cultured wild-type clb + E. coli CFT073 and its clbmutant. EIC+ = 646.14 ± 0.01 and 343.26 ± 0.01, which correspond to 13 and 14, respectively.
of unrelated SSBs 35 , and is comparable to some of the well-known DNA DSB inducers, which include (-)-lomaiviticin A (5.3:1) and bleomycin (9:1) 34, 36 , which supports the coupled strand-cleavage activity of colibactin. It is notable that under the same reaction condition, 11 displayed a stronger DNA DSB activity than bleomycin, which also requires the presence of a redox-active metal ion for DNA cleavage 37, 38 ( Supplementary Fig. 18 ). The observed Cu(ii)-mediated DSB activity of colibactin is reminiscent of the oxidative mechanism of DNA cleavage that involves a metal centre reduction 35, 39 . The addition of neocuproine, a specific Cu(i) chelator, completely sequestered the DSB activity of 11, which suggests that Cu(i) is an essential component for 11-induced DNA cleavage (Fig. 4c) . Surprisingly, the presence of a reducing agent, such as β-mercaptoethanol or dithiothreitol, had no obvious effect on the DSB activity of 11 (Fig. 4c ). We thus propose that the reduction of Cu(ii) to Cu(i) may be mediated by the DNA or by 11 itself, and the latter is supported by the free Cu(i) determination assays on incubation of 11 and Cu(ii) ( Supplementary Fig. 19 ). In addition, 10 demonstrated a comparable copper reduction activity to that of 11, which suggests that the same macrocyclic scaffold in both compounds could be the active centre for Cu(ii) binding and reduction ( Supplementary Figs. 19 and 20) . The parallel monitor of the mixture of 10 and Cu(ii) by HRMS further showed a loss of the mass signal for 10 over time which was accompanied by an approximately stoichiometric formation of Cu(i) ( Supplementary Fig. 21) , and also the presence of a new mass signal with an isotopic pattern of a copper-bound complex 40 (Supplementary Fig. 22 ). Although this new mass signal was weak and transient, which prevented its further characterization, this data supported the direct binding of 10 to copper and the instability of 10 in the presence of copper. We further determined the binding constant of copper with 10 to be ~4,120 M -1 ( Supplementary Fig. 23 ).
The oxidative mechanism of DNA cleavage was further probed by adding various reactive oxygen species scavengers. Plasmid DNA damage by 11 was not measurably influenced by the hydroxyl radical scavengers mannitol and dimethylsulfoxide (DMSO) (Fig. 4d) , which argues against participation of the freely diffusible hydroxyl radical in the observed cleavage and distinguishes the mechanism by which colibactin incises DNA from a sole Fenton-like one 41 . The addition of superoxide dismutase, which catalyses the conversion of the superoxide radical into hydrogen peroxide (H 2 O 2 ), did not measurably influence DNA cleavage by 11 (Fig. 4d) . In contrast, potassium iodide, a H 2 O 2 scavenger, and catalase, which mediates the decomposition of H 2 O 2 , significantly inhibited the cleavage reaction (Fig. 4d) . These results suggested that H 2 O 2 was involved in mediating DNA cleavage in vitro, consistent with the observation of a significant increase in H2-DCFDA fluorescence (a sensor of hydroxyl and peroxyl radicals, and of hydrogen peroxide production) in non-transformed human lung fibroblast cells infected by colibactin-producing E. coli 11 .
The DNA DSB activity of 11 was next compared to those of other precolibactins for a preliminary structure-activity relationship study. Under the same reaction conditions, 10 displayed a significantly weaker DSB activity than 11 ( Supplementary Fig. 18) , which demonstrates that the extra 5-hydroxyoxazole moiety in 11 was important to augment the DSB activity. The DSB activity of 5, a precolibactin that has previously demonstrated DNA-crosslinking activity due to its azaspirocyclopropane warhead, was also tested 24 . 5 did not display DNA-damaging activity even at concentrations as high as 5 mM ( Supplementary Fig. 18 ). DNA DSB activity of colibactin in cells. We next examined the DNA damaging activity of colibactin in various human cell lines. The production of phosphorylated histone H2AX (γH2AX) and translocation of the p53 binding protein 1 (53BP1) are early events in the cellular response to DNA DSBs 42, 43 . After four hours of exposure to 50 nM 13, HeLa cells showed the formation and colocalization of foci derived from γH2AX and 53BP1 (Fig. 5a ). By comparison, the γH2AX and 53BP1 foci were undetectable in cells treated with 50 nM 11 (Fig. 5a) , in contrast to the comparable activity of 13 and 11 in the pBR322 plasmid DNA strand scission assay. This result supported that maturation was a prerequisite for colibactin's genotoxicity in vivo 15 . In addition, 15, the mature product of 10 after ClbP cleavage ( Supplementary Fig. 24 ), also demonstrated a significantly lower activity than that of 13 (Fig. 5a) , consistent with the lower DSB activity of 10 than that of 11 in vitro ( Supplementary Fig. 18 ). The similar foci formation and colocalization were also observed in other cell lines, such as human normal colon epithelial FHC cells, human normal colon fibroblast CCD-112 CoN cells and colorectal cancer HCT-116 cells treated with 50 nM 13 ( Supplementary  Fig. 25 ), which established that the cellular response to 13 was not cell-line specific, consistent with previously reported cytopathic effects in various cell lines that were infected by clb + E. coli strains 9 . A neutral comet unwinding assay was also conducted as an effective and independent method to evaluate the occurrence of DNA DSBs in cells treated with 13 44 . Consistent with the results of γH2AX and 53BP1 induction, a four-hour exposure of HeLa cells to 13 caused accrued DNA lesions in a concentration-dependent manner, demonstrated by the migration of cleaved DNA fragments (comet tail) from the nucleoid (comet head) under the influence of an electric field (Fig. 5b) . Furthermore, the treatment of either EDTA or bathocuproinedisulfonic acid (BCS), an extracellular Cu-sequestering agent, significantly alleviated the levels of DNA damage caused by the purified compound 13 or the infection of clb + E. coli CFT073 (Fig. 5c,d and Supplementary Fig. 26 ), which is in agreement with the observed dependence of copper for colibactininduced DNA DSBs in vitro.
Discussion
Despite extensive studies on the biology of the clb pathogenicity island and the chemistry of the clb encoding enzymes, the genotoxic colibactin metabolite with intrinsic DNA DSBs activity had escaped all screening surveillance in the past decade. Through strain engineering, large-scale fermentation and metabolite comparison, we have identified and characterized the highly sought genotoxic colibactin metabolite, colibactin-645 (13) . The biosynthesis of 13 requires all the predicted biosynthetic enzymes encoded on the clb pathogenicity island; more importantly, 13 recapitulates its pre-assumed DNA DSB activity both in vitro and in cell cultures, which distinguishes 13 from all previously identified metabolites associated with this pathogenicity island. Interestingly, although macrocyclic colibactins, which included 10, 11, 13 and 15, required copper for their bioactivity, they quickly degraded in the presence of copper, which prevented the direct characterization of any colibactin·Cu complex. This is akin to the instability of the activated bleomycin that was suggested to have a half-life of only several minutes at 4 °C after binding to a reduced transition metal 45 . In addition to the low abundance and chemical lability, the macrocyclic mature colibactin appeared to be a polar compound that stayed in the aqueous phase during organic solvent extraction, which could further contribute to the difficulty in the genotoxic metabolite detection.
The biosynthesis of 13, as well as of 8 and 11, features a new fate for the atypical aminomalonyl extender unit utilized by PKSs. The incorporation of this aminomalonyl extender unit was previously elucidated through a traditional decarboxylative Claisen condensation in zwittermicin, guadinomine and colibactin biosynthesis 28,46,47 . In particular, ClbK PKS was shown to promote the decarboxylative condensation of the aminomalonyl unit that contributes for thiazole and 2,5-dihydro-5-hydroxyoxazole formation in the biosynthesis of 10 28 . In this study, we showed that an amidase, ClbL, was required for the biosynthesis of 8 and 11, and further proposed that ClbL promotes the amide bond formation through nucleophilic attack of the amine in the aminomalonate extender unit attached to the ClbK or ClbO, which leads to the generation of the terminal 5-hydroxy-4-oxazolecarboxylic acid moiety in 8 or 11 (and thus 13), respectively. Furthermore, identification of the precolibactin metabolite 12 suggests that, similar to ClbK, ClbO is capable of catalysing the decarboxylative condensation of the aminomalonyl unit, although this activity is outcompeted by the activity of ClbL, which results in a much higher titre of 11 than of 12. This finding is consistent with the recent independent discovery 48 that shows that ClbL is a promiscuous amide bond-forming enzyme that links aminoketone and β-keto thioester substrates. The relaxed substrate specificity of ClbL is probably one of the main contributing factors to the production of several complex colibactin metabolites associated with the clb island, including the markedly different colibactin metabolites with DNA crosslinking activities that were recently identified in independent studies 49 .
Based on the DNA damage assays, both in vitro and in cells, we propose the following mechanism for copper-mediated DNA DSBs by colibactin-645 (13) ( Supplementary Fig. 27 ). After being secreted from a producing bacterium that localizes close to or in contact with the intestinal brush border 10 , 13 binds to exchangeable copper in the intestinal lumen, probably coming from diet 50 , to form a colibactin·Cu(ii) complex. The macrocyclic colibactin was determined to have a higher binding affinity for Cu(ii) than some of the known copper-binding natural products, such as bleomycin and tambjamine 51 , which supports the physiological relevance of the suggested complex formation with Cu(ii). This complex is quickly transported into the epithelial cell as it reduces to a colibactin·Cu(i) complex, and the coordination of O 2 to this cuprous complex in cells generates 'activated colibactin' that attacks DNA and initiates DNA cleavage. Cu(ii)─O • (or Cu(iii)═O) is proposed to be the active species in the activated colibactin complex susceptible to DNA carbon-hydrogen bond activation 39 , which is consistent with the observed inhibitory effects of H 2 O 2 scavengers on the DNA cleavage reaction in vitro, as colibactin·Cu(ii)─OOH is a key intermediate to colibactin·Cu(ii)─O • (Supplementary Fig. 27 ). Additionally, we do not exclude the possibility that 13 quickly enters the epithelial cell and then binds the intracellular copper to exert its activity. This mechanism is analogous to that proposed for the generation of activated bleomycin in vivo, but differs mainly in the metal usage and the intrinsic metal reduction activity of the compounds 37, 38 .
The unusual heterocycle-fused macrocycle in 13 is important for copper binding and reduction, as only macrocyclic colibactins, such as 10 and 11, demonstrated a strong and comparable Cu(ii) reduction activity. In addition, the comparison between the DSB activity of 10 and 11, as well as of 15 and 13, highlights the significance of the terminal 5-hydroxyoxazole moiety for DNA DSB activity. We speculate that the thiazole/5-hydroxyoxazole tail found in 11 and 13 may serve as the DNA intercalating element, similar to the function of the bithiazole moiety found in bleomycin 37, 38 . Based on the comparative DSB activity of 11 and 13 in vitro but a drastically different solubility as well as the significantly lower activity of 11 in cellular assays, we further propose that the loss of the N-terminal fatty acyl-asparagine residue as the prodrug motif facilitates the access of mature colibactin-645 to target eukaryotic cells 15 . Although many secondary metabolites are reported to induce DNA DSBs, a majority of them function via indirect mechanisms (such as by inhibiting topoisomerase complexes 52 ), and few of them cleave the DNA double-strand directly 53 . 13 thus represents a novel molecular scaffold that exerts a direct DNA DSB activity, and provides a model for designing and synthesizing potent DNA cleaving agents, from synthetic restriction 'enzymes' to chemotherapeutic agents.
Given that DNA crosslinking was also observed in human cell lines incubated with colibactin-producing E. coli 54, 55 , we speculate that the overall genotoxic effect of the clb island may arise from a mixture of metabolites with different modes of action, which include but are not limited to DNA crosslinking and DNA DSB activities. This is consistent with the predicted comprehensive role of colibactins in mediating diverse bacteria-host interactions [6] [7] [8] 17, 18, [56] [57] [58] .
In summary, we identified and characterized a novel genotoxic colibactin metabolite, provided conclusive evidence that macrocyclic colibactin directly mediates DNA damage and shed light on the long-standing mystery of the molecular mechanism that underlies colibactin-induced DNA DSBs. Our discoveries thus lay out a framework for future investigations that could enhance our understanding of the clb pathogenicity island from human gut microbes, and enable further mechanistic interrogation of colibactin-induced DNA DSBs and colibactin-related CRC incidence and prevention. Corresponding author(s): Wenjun Zhang, Pei-Yuan Qian Last updated by author(s): May 23, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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